Limitations of simulation models for cervical cancer screening – Authors' reply

Talía Malagón; Shalini Kulasingam; Eduardo L. Franco

doi:10.1016/S1470-2045(19)30012-9

Limitations of simulation models for cervical cancer screening – Authors' reply

Talía Malagón, Shalini Kulasingam, Eduardo L. Franco

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e69
Journal	The Lancet Oncology
Volume	20
Issue number	2
DOIs	https://doi.org/10.1016/S1470-2045(19)30012-9
State	Published - Feb 2019

Bibliographical note

Funding Information:
TM reports research funding from the Canadian Institutes of Health Research (CIHR) during the conduct of the study. ELF reports research funding from CIHR during the conduct of the study; grants from Merck, grants and non-financial support from Roche, personal fees from Merck, and personal fees from GlaxoSmithKline outside of the submitted work. SK declares no competing interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/S1470-2045(19)30012-9

Find It

Find It at U of M Libraries

Cite this

@article{f3d7171bfaf24b38a7b8836cf8105038,

title = "Limitations of simulation models for cervical cancer screening – Authors' reply",

author = "Tal{\'i}a Malag{\'o}n and Shalini Kulasingam and Franco, {Eduardo L.}",

note = "Funding Information: TM reports research funding from the Canadian Institutes of Health Research (CIHR) during the conduct of the study. ELF reports research funding from CIHR during the conduct of the study; grants from Merck, grants and non-financial support from Roche, personal fees from Merck, and personal fees from GlaxoSmithKline outside of the submitted work. SK declares no competing interest.",

year = "2019",

month = feb,

doi = "10.1016/S1470-2045(19)30012-9",

language = "English (US)",

volume = "20",

pages = "e69",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Limitations of simulation models for cervical cancer screening – Authors' reply

AU - Malagón, Talía

AU - Kulasingam, Shalini

AU - Franco, Eduardo L.

N1 - Funding Information: TM reports research funding from the Canadian Institutes of Health Research (CIHR) during the conduct of the study. ELF reports research funding from CIHR during the conduct of the study; grants from Merck, grants and non-financial support from Roche, personal fees from Merck, and personal fees from GlaxoSmithKline outside of the submitted work. SK declares no competing interest.

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85060881389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060881389&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30012-9

DO - 10.1016/S1470-2045(19)30012-9

M3 - Letter

C2 - 30712802

AN - SCOPUS:85060881389

SN - 1470-2045

VL - 20

SP - e69

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -

Limitations of simulation models for cervical cancer screening – Authors' reply

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this